Prognostic factors for recurrence in early stage adult granulosa cell tumor of the ovary
Autor: | Maria Sotiropoulou, Ioannis Biliatis, Nikolaos Thomakos, Alexandros Rodolakis, I. Koutroumpa, Michalis Liontos, Aris Bamias, Georgios D. Vlachos |
---|---|
Rok vydání: | 2016 |
Předmět: |
Oncology
Adult endocrine system medicine.medical_specialty Granulosa cell Ovary Cohort Studies 03 medical and health sciences 0302 clinical medicine Internal medicine Medicine Humans Stage (cooking) Pathological Aged Granulosa Cell Tumor Neoplasm Staging Retrospective Studies 030219 obstetrics & reproductive medicine business.industry Obstetrics and Gynecology Retrospective cohort study General Medicine Middle Aged medicine.disease Prognosis Granulosa cell tumors medicine.anatomical_structure 030220 oncology & carcinogenesis Female Neoplasm Recurrence Local business Ovarian cancer Cohort study |
Zdroj: | Archives of gynecology and obstetrics. 294(5) |
ISSN: | 1432-0711 |
Popis: | Adult granulosa cell tumors (AGCTs) account for less than 5 % of all ovarian malignancies, whereas the majority (95 %) occurs after the age of 30 (adult-type) and present at an early stage. Aim of this study is to identify clinical and pathological risk factors for recurrence in early stage AGCTs.Retrospective review of patients with AGCT of the ovary, treated surgically at our institution from 1996 to 2011. Clinical, pathological and follow-up data were collected. Systematic analysis was performed to determine variables for predicting recurrence.In total, 43 patients were identified. The mean age at diagnosis was 54.3 years and 65.1 % of them were postmenopausal. All patients underwent surgical staging and intraoperative rupture of the tumor occurred in four of them (9.3 %). The majority of the cases were staged as IA (72.1 %) while 10 (23.3 %) were staged as IC and only two patients as IIB. Mitotic index was 4 or more in 34.9 % of the patients and nuclear atypia was moderate to high in 60.5 %. During follow-up period (mean 9.2 years), recurrence occurred in three patients (7 %) with no deaths recorded so far. The cumulative recurrence free rate for the first 2 years was 97.6 % (SE = 2.4 %), for 5 years 94.9 % (SE = 3.5 %) and for 10 years 91.0 % (SE = 5.1 %).Tumor size, stage and mitotic index proved to be independent predictors for recurrence at the multivariate analysis.Recurrence in early stage AGCT seems to be associated with stage, tumor size and mitotic index. All the above should be taken into consideration when tailored postoperative management is planned. |
Databáze: | OpenAIRE |
Externí odkaz: |